Fact Source: Financial Supervisory Service DART
Market: KOSPI (000660)
💡 3-Second Summary
SK Hynix has submitted a disclosure regarding one worker who passed away while receiving medical care for an approved occupational illness under the Industrial Accident Compensation Insurance Act.
📊 [Key Summary & Financial Figures]
- Company Name: SK Hynix Inc.
- Location of Occurrence: Hospital where the affected worker was receiving medical treatment
- Details of Disaster: Death during medical care (June 25, 2026) after approval of occupational illness under the Industrial Accident Compensation Insurance Act (March 5, 2025)
- Casualties: 1 Deceased, 0 Injured
- Date of Occurrence: June 25, 2026
- Date Reported to Ministry of Employment and Labor: June 26, 2026
- Measures Taken and Future Countermeasures: On-site investigation and root cause identification planned by the Ministry of Employment and Labor
- Other Key Decision Details:
- Whether the case falls under a serious industrial accident pursuant to the Occupational Safety and Health Act has not yet been confirmed.
- Correction disclosure will be made once relevant details are confirmed through ongoing investigations.
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verifying Investigation Results from the Ministry of Employment and Labor and Subsequent Correction Disclosures
This disclosure reports the death of a worker undergoing medical care for an approved occupational illness and the notice submitted to authorities. Monitoring whether official investigations confirm this event as a serious industrial accident under the Occupational Safety and Health Act is important to understand related legal risks and procedural developments. Relevant details and progress can be confirmed in future correction disclosures and subsequent periodic reports (Quarterly, Half-Year, or Annual Reports).
📢 Disclaimer and Source Notice
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s DART system.
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
